Progress and Disparities in Lung Cancer Screening in Japan: A Bayesian Analysis Toward Achieving Health Japan 21 Targets
Cancers · 07.05.2026 · 18 (10) · 1498
DOI: 10.3390/cancers18101498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 07.05.2026. Verfasst von Takao Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Health Policy and Economics, Hitotsubashi Institute for Advanced Study (HIAS), Hitotsubashi University, Kunitachi, Tokyo 186-8601…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hirose Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Japan’s national health promotion plan, Health Japan 21, aims to achieve 60% lung cancer screening coverage by 2028. This study projected screening uptake through 2028 and estimated the probability of achieving this target at the national and prefectural levels, stratified by gender.
Methods
We analyzed lung cancer screening in Japan using the Comprehensive Survey of Living Conditions data (2013, 2016, 2019, 2022) for adults aged 40–69. Bayesian linear regressions estimated trends in logit-transformed screening coverage, with projections through 2028. We estimated annual changes, the probability of reaching 60% by 2028, and the first year in which the probability of target attainment exceeded 80%.
Results
National screening coverage increased from 42.3% in 2013 to 49.7% in 2022, with an annual percentage-point change of 0.83 (95% CrI: −0.20 to 1.80). At this rate, the probability of reaching 60% by 2028 is 12.2%. Only 11 of 47 prefectures are projected to meet the target, while 4 (Kyoto, Kumamoto, Kagoshima, and Okinawa) are unlikely to reach it. Sex disparities were observed, with the probability of achievement at 25.4% for men versus 7.1% for women. The female annual change (0.99) exceeded the male annual change (0.65).
Conclusions
Lung cancer screening participation varies significantly across regions and between genders, reflecting uneven progress toward the national goal. If current trends continue, achieving 60% coverage by 2028 will be challenging for most prefectures. Policy and system reforms could speed up uptake by focusing on prefectures and populations with the lowest participation rates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center for Health Policy and Economics, Hitotsubashi Institute for Advanced Study (HIAS), Hitotsubashi University, Kunitachi, Tokyo 186-8601, Japan.
- Graduate School of Public Health, St. Luke's International University, Chuo, Tokyo 104-0045, Japan.
- Division of Population Data Science, National Cancer Center Institute for Cancer Control, Chuo, Tokyo 104-0045, Japan.
- Global Health Policy Department, School of International Health, Graduate School of Medicine, University of Tokyo, Bunkyo, Tokyo 113-8654, Japan.
ORCID-Profile: Takao Suzuki, Hasan Jamil
Förderung
- Hirose Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Suzuki, T., Jamil, H., Abubakar, A. K., Gyeltshen, T., Babu, H. W., & Nguyen, P. T. (2026). Progress and Disparities in Lung Cancer Screening in Japan: A Bayesian Analysis Toward Achieving Health Japan 21 Targets. Cancers, 18(10), 1498. https://doi.org/10.3390/cancers18101498
Vancouver
Suzuki T, Jamil H, Abubakar AK, Gyeltshen T, Babu HW, Nguyen PT. Progress and Disparities in Lung Cancer Screening in Japan: A Bayesian Analysis Toward Achieving Health Japan 21 Targets. Cancers. 2026;18(10):1498. doi:10.3390/cancers18101498
BibTeX
@article{Suzuki2026,
author = {Suzuki, Takao and Jamil, Hasan and Abubakar, Aminu Kende and Gyeltshen, Tshewang and Babu, Hellen Wairimu and Nguyen, Phuong The},
title = {Progress and Disparities in Lung Cancer Screening in Japan: A Bayesian Analysis Toward Achieving Health Japan 21 Targets},
journal = {Cancers},
year = {2026},
volume = {18},
number = {10},
pages = {1498},
doi = {10.3390/cancers18101498}
}
EUVIMED